AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)
CUSIP: 03152W109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 316,644,581
- Total 13F shares
- 312,179,498
- Share change
- -7,717,060
- Total reported value
- $2,460,108,114
- Put/Call ratio
- 96%
- Price per share
- $7.88
- Number of holders
- 284
- Value change
- -$41,597,231
- Number of buys
- 154
- Number of sells
- 126
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.4%
|
22,765,804
|
$171,198,846 | -$38,641,761 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.3%
|
29,407,588
|
$168,505,480 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
9.2%
|
29,123,962
|
$166,880,303 | — | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13D/G
13F
|
Company |
4.9%
|
15,025,000
|
$118,397,000 | -$43,143,000 | 30 Sep 2025 | |
| Redmile Group, LLC |
13D/G
13F
|
Company |
4.6%
|
14,184,495
|
$106,667,402 | $0 | 31 Dec 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
14,642,157
|
$83,899,560 | — | 30 Jun 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
3.8%
|
11,900,000
|
$68,187,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
11,568,097
|
$66,285,196 | — | 30 Jun 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.4%
|
7,722,318
|
$44,249,000 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
2.4%
|
7,412,830
|
$43,290,927 | -$82,061,910 | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.3%
|
7,421,640
|
$42,525,997 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.2%
|
6,847,275
|
$39,234,882 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
6,706,489
|
$38,433,631 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2%
|
6,362,250
|
$36,455,692 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.9%
|
5,974,643
|
$34,234,705 | — | 30 Jun 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
1.8%
|
5,610,513
|
$32,148,239 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
4,342,755
|
$24,883,985 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
4,292,362
|
$24,595,237 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
3,907,569
|
$22,783,766 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.2%
|
3,726,468
|
$21,352,662 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.1%
|
3,631,801
|
$20,810,220 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.1%
|
3,533,854
|
$20,248,983 | — | 30 Jun 2025 | |
| Prosight Management, LP |
13F
|
Company |
1.1%
|
3,480,044
|
$19,940,652 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
3,466,911
|
$19,865,400 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1%
|
3,279,047
|
$18,788,939 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
1%
|
3,235,538
|
$18,539,633 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.98%
|
3,089,806
|
$17,704,589 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.87%
|
2,760,314
|
$15,816,599 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.87%
|
2,753,710
|
$15,778,163 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
2,548,056
|
$14,600,361 | — | 30 Jun 2025 | |
| Blackstone Inc. |
13F
|
Company |
0.78%
|
2,467,104
|
$14,136,506 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.75%
|
2,386,446
|
$13,674,336 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.72%
|
2,285,400
|
$13,095,342 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
2,222,841
|
$12,736,879 | — | 30 Jun 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.7%
|
2,212,690
|
$12,678,714 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.7%
|
2,210,271
|
$12,664,852 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.7%
|
2,202,944
|
$12,622,869 | — | 30 Jun 2025 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.68%
|
2,161,202
|
$12,383,687 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.64%
|
2,013,593
|
$11,537,888 | — | 30 Jun 2025 | |
| M&G Plc |
13F
|
Company |
0.6%
|
1,884,985
|
$11,309,910 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.62%
|
1,960,334
|
$11,232,714 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.58%
|
1,839,249
|
$10,538,897 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.53%
|
1,693,292
|
$9,702,563 | — | 30 Jun 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.48%
|
1,515,051
|
$8,681,242 | — | 30 Jun 2025 | |
| John F. Crowley |
3/4/5
|
Executive Chairman, Director |
—
mixed-class rows
|
888,038
mixed-class rows
|
$8,521,769 | — | 01 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.46%
|
1,444,107
|
$8,274,733 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.44%
|
1,406,563
|
$8,059,605 | — | 30 Jun 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.43%
|
1,353,498
|
$7,756,000 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
1,303,964
|
$7,471,713 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.4%
|
1,267,303
|
$7,261,646 | — | 30 Jun 2025 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q3 2025
As of 30 Sep 2025,
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by
284 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
312,179,498 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Avoro Capital Advisors LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, Vestal Point Capital, LP, CITADEL ADVISORS LLC, and Point72 Asset Management, L.P..
This page lists
285
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
269
Q3 2025 holders
284
Holder diff
15
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.